Last week, we discussed a new DEA interim rule that some CBD insiders say poses an existential threat to the industry. In essence it rules that if any substance produced in the manufacturing of CBD products contains more than 0.3% THC it is a schedule I controlled substance and illegal.
L.A. Weekly reached out to the DEA which said it is aware of the industry’s concerns and said it is evaluating the options and implied it is more focused on drugs like crystal meth and fentanyl.
- At Canna Law Blog, attorney Daniel Shortt wrote, “I do not buy this misdirection for a minute.”
- The DEA’s public comment period is open until October 20. Comments can be made here and should reference, “RIN 1117- AB53/ Docket No. DEA-500”
